Democrats say drug price increases could wipe out PhRMA's $80 billion reform pledge
This article was originally published in Scrip
Executive Summary
Any savings from the pharmaceutical industry's $80 billion commitment to reduce healthcare spending over 10 years could be largely wiped out if drug prices are allowed to rise unabated, Democratic lawmakers said at a US House hearing on December 8th.